Is oxcarbazepine a contraindication to electroconvulsive therapy (ECT)?

Oxcarbazepine is NOT a contraindication to ECT

Oxcarbazepine can be safely used during ECT, though it raises seizure threshold and may require higher stimulus doses to achieve adequate seizures. There are no absolute contraindications to ECT, and anticonvulsants including oxcarbazepine are not listed as contraindications 1.

Key Evidence

Guidelines on Anticonvulsants and ECT

The American Academy of Child and Adolescent Psychiatry practice parameters explicitly state that there are no absolute contraindications to ECT 1. The guidelines specifically address seizure disorders and anticonvulsants:

• ECT may be used in the presence of a seizure disorder when indicated for psychiatric illness 1
• Adult data indicate ECT does not have long-term effects on seizure threshold and may even reduce seizure frequency in patients with intractable seizures 1
• While guidelines recommend discontinuing medications "whenever possible" during ECT, they acknowledge that "if clinically necessary, medications may be administered accompanied by appropriate monitoring" 1

Specific Concerns with Oxcarbazepine

The main issue is technical, not safety-related:

• Carbamazepine (structurally related to oxcarbazepine) has been reported to cause failure to induce seizures during ECT 1
• Recent research confirms that oxcarbazepine significantly raises ECT seizure threshold more than valproate (mean threshold 243.9 mC vs 177.7 mC vs 138.7 mC in controls) 2
• Age, use of carbamazepine/oxcarbazepine, and anticonvulsant dose were each significantly associated with higher seizure threshold 2

Clinical Implications

Start with higher initial stimulus doses when patients are on oxcarbazepine to avoid repeated sub-convulsive stimuli 2. One case report documented successful ECT resumption after status epilepticus when oxcarbazepine had been discontinued, suggesting that maintaining oxcarbazepine during ECT may actually provide protective effects against prolonged seizures 3.

Practical Management Algorithm

1. Do not discontinue oxcarbazepine unless clinically feasible and safe for seizure control
2. Anticipate higher seizure threshold: Start with stimulus doses 50-75% higher than typical for age
3. Use stimulus dose titration at first session to determine individual threshold 2
4. Monitor seizure duration closely - aim for adequate seizure (≥25 seconds motor, ≥15 seconds EEG)
5. Increase stimulus charge if seizures are inadequate rather than discontinuing the anticonvulsant 3

Important Caveats

• The 2007 systematic review found no severe adverse effects or complications with anticonvulsant-ECT combinations, only occasional difficulty eliciting seizures 4
• Benzodiazepines raise seizure threshold more problematically than anticonvulsants like oxcarbazepine 1
• Recent evidence (2024) confirms that concomitant psychotropic medication during ECT does not reduce effectiveness 5

Bottom line: Proceed with ECT while maintaining oxcarbazepine, but use higher initial stimulus doses and careful seizure monitoring.